At its Annual General Meeting, Fresenius Medical Care shareholders approved a proposed dividend of EUR 1.44 per share for the 2024 fiscal year. This represents a 21% increase compared to the previous year's dividend of EUR 1.19 per share, marking the highest dividend per share in the company's history.
The approval, supported by a clear majority of 96.85% of shareholders, aligns with Fresenius Medical Care's dividend policy to link payouts with the development of net income excluding special items. This decision underscores the company's commitment to returning value to its shareholders.
The AGM also renewed authorizations for the Management Board to increase the company's share capital and to issue option and/or convertible bonds, providing flexibility for future financing needs. These approvals reflect confidence in the company's strategic direction and financial health.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.